statistiche ricercatore

Continente	#
NA - Nord America	985
AS - Asia	875
EU - Europa	573
SA - Sud America	220
Continente sconosciuto - Info sul continente non disponibili	20
AF - Africa	9
OC - Oceania	2
Totale	2.684

Nazione	#
US - Stati Uniti d'America	913
SG - Singapore	310
CN - Cina	207
IT - Italia	201
BR - Brasile	162
RU - Federazione Russa	142
VN - Vietnam	123
BD - Bangladesh	68
HK - Hong Kong	47
CA - Canada	41
DE - Germania	39
FR - Francia	34
GB - Regno Unito	33
IN - India	32
FI - Finlandia	28
SE - Svezia	21
ID - Indonesia	18
MX - Messico	18
AR - Argentina	17
PL - Polonia	17
TR - Turchia	17
EC - Ecuador	15
NL - Olanda	12
IQ - Iraq	10
AT - Austria	9
CO - Colombia	7
ES - Italia	7
PE - Perù	6
PK - Pakistan	6
VE - Venezuela	6
JP - Giappone	5
CH - Svizzera	4
IL - Israele	4
MY - Malesia	4
PY - Paraguay	4
UA - Ucraina	4
UZ - Uzbekistan	4
CL - Cile	3
JM - Giamaica	3
JO - Giordania	3
KZ - Kazakistan	3
LT - Lituania	3
SI - Slovenia	3
BY - Bielorussia	2
CI - Costa d'Avorio	2
CR - Costa Rica	2
DO - Repubblica Dominicana	2
GR - Grecia	2
KE - Kenya	2
NI - Nicaragua	2
NO - Norvegia	2
RO - Romania	2
TH - Thailandia	2
AE - Emirati Arabi Uniti	1
AF - Afghanistan, Repubblica islamica di	1
AL - Albania	1
AU - Australia	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BB - Barbados	1
BE - Belgio	1
CG - Congo	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
GE - Georgia	1
GT - Guatemala	1
IE - Irlanda	1
LB - Libano	1
LV - Lettonia	1
MA - Marocco	1
NC - Nuova Caledonia	1
NP - Nepal	1
OM - Oman	1
PH - Filippine	1
PS - Palestinian Territory	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
SV - El Salvador	1
SY - Repubblica araba siriana	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
ZA - Sudafrica	1
Totale	2.664

Nome	#
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis	332
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study	279
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis	254
Sex-specific associations of myocardial perfusion imaging with outcomes in patients with suspected chronic coronary syndrome	232
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis	229
Tissue Characterization in Cardiac Amyloidosis	225
Positron emission tomography in cardiac amyloidosis: current evidence and future directions	221
PET and Cardiac Amyloidosis	215
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis	212
Automated Neural Architecture Search for Cardiac Amyloidosis Classification from [18F]-Florbetaben PET Images	199
Diagnosis and Prognostication With PET Imaging: The (Next) Future in Light Chain Amyloidosis	183
Diagnosis and Prognostication With PET Imaging: The (Next) Future in Light Chain Amyloidosis	57
Dogmas and heresies in coronary blood flow regulation	46
Totale	2.684

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2023/2024	24	0	0	4	4	0	3	2	1	0	0	0	10
2024/2025	445	8	14	28	4	20	18	53	73	31	16	71	109
2025/2026	1.980	135	262	197	290	185	137	140	101	167	122	133	111
2026/2027	235	41	49	117	28	0	0	0	0	0	0	0	0
Totale													2.684